Objective: This study examined the course of illness in patients with obses
sive-compulsive disorder (OCD) over a 2-year period.
Method: Sixty-six patients with a primary diagnosis of DSM-III-R OCD were f
ollowed prospectively for 2 years. Baseline information was collected on de
mographic characteristics, Axis I and II diagnoses, and severity of OCD sym
ptoms. Follow-up measures obtained at 3, 6, 12, and 24 months after baselin
e assessment included information on symptomatic and diagnostic status as w
ell as behavioral and somatic treatments received.
Results: The probability of full remission from OCD over the 2-year period
was 12%. The probability of partial remission was 47%. After achieving remi
ssion from OCD, the probability of relapse was 48%. No factors were identif
ied that significantly predicted full or partial remission. Seventy-seven p
ercent (N = 51) of the subjects received a serotonin reuptake inhibitor (SR
I) for greater than or equal to 12 weeks, and 68% (N = 45) received medium-
to-high doses of SRIs for greater than or equal to 12 weeks. Only 18% recei
ved a full trial of behavior therapy.
Conclusion: Despite exposure to at least 1 adequate trial of an SRI, the li
kelihood of full remission of OCD in this study was low. Results of this st
udy also suggest that behavior therapy may be underutilized.